Login
$RAPP
$24.82 -$1.33 (5.09%) Live

$RAPP SEC Filings

Filed On Filing
16 Nov 2026 SCHEDULE 13G/A
04 Nov 2026 10-Q
04 Nov 2026 8-K: Results of Operations and Financial Condition

Positive topline results from Phase 2 trial of RAP-219 in bipolar mania; initiation of two Phase 3 trials in bipolar mania expected in 2H 2027

03 Nov 2026 Form 4: Third Rock Ventures V, L.p., Director and 5 others

Received 1,428,571 shares as a grant or award ($30M)

30 Oct 2026 Form 4: Healy James, Director

Bought 969,480 shares ($20.4M)

30 Oct 2026 8-K: Entry into a Material Definitive Agreement; Results of Operations and Financial Condition +2 more

This Cross-Reference Table does not constitute part of the Indenture and shall not have any bearing on the interpretation of any of its terms or provisions.

30 Oct 2026 424B5
30 Oct 2026 424B5
29 Oct 2026 305B2
28 Oct 2026 FWP
28 Oct 2026 FWP
28 Oct 2026 FWP
28 Oct 2026 FWP
27 Oct 2026 424B5
27 Oct 2026 424B5
23 Oct 2026 Form 4: Ceesay Abraham, Director

Sold 2,210 shares ($64.4K)

23 Oct 2026 Form 4: Sanchez Ramiro, Director

Bought 3,600 shares ($98.5K)

22 Oct 2026 Form 4: Silva Paul M, Director

Bought 3,680 shares ($99.6K)

22 Oct 2026 Form 4: Young Wendy B., Director

Bought 3,789 shares ($100K)

22 Oct 2026 Form 4: Paul Steven M, Director

Bought 35,714 shares ($974K)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support